Literature DB >> 30345547

Insights into major facilitator superfamily domain-containing protein-2a (Mfsd2a) in physiology and pathophysiology. What do we know so far?

Pinar Eser Ocak1, Umut Ocak1, Prativa Sherchan1, John H Zhang1, Jiping Tang1.   

Abstract

Major facilitator superfamily domain-containing protein-2a (Mfsd2a) which was considered as an orphan transporter has recently gained attention for its regulatory role in the maintenance of proper functioning of the blood-brain barrier. Besides the major role of Mfsd2a in maintaining the barrier function, increasing evidence has emerged with regard to the contributions of Mfsd2a to various biological processes such as transport, cell fusion, cell cycle, inflammation and regeneration, managing tumor growth, functioning of other organs with barrier functions or responses to injury. The purpose of this article is to review the different roles of Mfsd2a and its involvement in the physiological and pathophysiological processes primarily in the central nervous system and throughout the mammalian body under the lights of the current literature.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Mfsd2a; blood-brain barrier; brain; docosahexaenoic acid; transport

Mesh:

Substances:

Year:  2018        PMID: 30345547      PMCID: PMC6476709          DOI: 10.1002/jnr.24327

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  116 in total

Review 1.  ERAD: the long road to destruction.

Authors:  Birgit Meusser; Christian Hirsch; Ernst Jarosch; Thomas Sommer
Journal:  Nat Cell Biol       Date:  2005-08       Impact factor: 28.824

Review 2.  Structure and function of the blood-brain barrier.

Authors:  N Joan Abbott; Adjanie A K Patabendige; Diana E M Dolman; Siti R Yusof; David J Begley
Journal:  Neurobiol Dis       Date:  2009-08-05       Impact factor: 5.996

Review 3.  The endoplasmic reticulum: A hub of protein quality control in health and disease.

Authors:  Lisa Vincenz-Donnelly; Mark S Hipp
Journal:  Free Radic Biol Med       Date:  2017-03-29       Impact factor: 7.376

4.  Mechanism of action of tunicamycin on the UDP-GlcNAc:dolichyl-phosphate Glc-NAc-1-phosphate transferase.

Authors:  A Heifetz; R W Keenan; A D Elbein
Journal:  Biochemistry       Date:  1979-05-29       Impact factor: 3.162

5.  Both maternal and offspring Elovl2 genotypes determine systemic DHA levels in perinatal mice.

Authors:  Anna M Pauter; Sofia Trattner; Amanda Gonzalez-Bengtsson; Emanuela Talamonti; Abolfazl Asadi; Olga Dethlefsen; Anders Jacobsson
Journal:  J Lipid Res       Date:  2016-11-18       Impact factor: 5.922

6.  A placenta-specific receptor for the fusogenic, endogenous retrovirus-derived, human syncytin-2.

Authors:  Cécile Esnault; Stéphane Priet; David Ribet; Cécile Vernochet; Thomas Bruls; Christian Lavialle; Jean Weissenbach; Thierry Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

Review 7.  Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Authors:  Robert D Bell; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2009-03-25       Impact factor: 17.088

8.  Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid.

Authors:  Long N Nguyen; Dongliang Ma; Guanghou Shui; Peiyan Wong; Amaury Cazenave-Gassiot; Xiaodong Zhang; Markus R Wenk; Eyleen L K Goh; David L Silver
Journal:  Nature       Date:  2014-05-14       Impact factor: 49.962

Review 9.  The endoplasmic reticulum-mitochondria connection: one touch, multiple functions.

Authors:  Saverio Marchi; Simone Patergnani; Paolo Pinton
Journal:  Biochim Biophys Acta       Date:  2013-11-08

10.  Intraperitoneal hypertension, a novel risk factor for sepsis-associated encephalopathy in sepsis mice.

Authors:  Yu-Jing He; Hao Xu; Yao-Jie Fu; Ji-Yan Lin; Min-Wei Zhang
Journal:  Sci Rep       Date:  2018-05-25       Impact factor: 4.379

View more
  7 in total

1.  Transcellular routes of blood-brain barrier disruption.

Authors:  Michelle A Erickson; William A Banks
Journal:  Exp Biol Med (Maywood)       Date:  2022-03-04

2.  Overexpression of Mfsd2a attenuates blood brain barrier dysfunction via Cav-1/Keap-1/Nrf-2/HO-1 pathway in a rat model of surgical brain injury.

Authors:  Pinar Eser Ocak; Umut Ocak; Prativa Sherchan; Marcin Gamdzyk; Jiping Tang; John H Zhang
Journal:  Exp Neurol       Date:  2020-01-16       Impact factor: 5.330

3.  Influence of traumatic brain injury on extracellular tau elimination at the blood-brain barrier.

Authors:  Maxwell Eisenbaum; Andrew Pearson; Arissa Gratkowski; Benoit Mouzon; Michael Mullan; Fiona Crawford; Joseph Ojo; Corbin Bachmeier
Journal:  Fluids Barriers CNS       Date:  2021-10-26

Review 4.  Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer's Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue.

Authors:  Rory J Heath; Thomas R Wood
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

5.  Identification of Significant Modules and Targets of Xian-Lian-Jie-Du Decoction Based on the Analysis of Transcriptomics, Proteomics and Single-Cell Transcriptomics in Colorectal Tumor.

Authors:  Cheng-Tao Yu; Tongqing Chen; Sicheng Lu; Wenlong Hu; Qinchang Zhang; Jiani Tan; Dongdong Sun; Liu Li; Xin Sun; Changliang Xu; Yueyang Lai; Minmin Fan; Zhengjie Shen; Weixing Shen; Haibo Cheng
Journal:  J Inflamm Res       Date:  2022-03-01

6.  Association of cluster determinant 36, scavenger receptor class B type 1, and major facilitator superfamily domain containing the 2a genetic polymorphism with serum lipid profile in aging population with type 2 diabetes mellitus.

Authors:  Xixiang Wang; Xiaojun Ma; Jingjing Xu; Yujie Guo; Shaobo Zhou; Huiyan Yu; Linhong Yuan
Journal:  Front Nutr       Date:  2022-09-14

7.  Decreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer's Disease.

Authors:  María Sánchez-Campillo; María José Ruiz-Pastor; Antonio Gázquez; Juan Marín-Muñoz; Fuensanta Noguera-Perea; Antonio J Ruiz-Alcaraz; Salvadora Manzanares-Sánchez; Carmen Antúnez; Elvira Larqué
Journal:  Int J Mol Sci       Date:  2019-12-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.